Claassen, Daniel O.

From the Departments of Neurosurgery (A.R.R., P.-F.D., M.R.), Neuroradiology (P.-F.D., J.C., R.I.M., P.W., A.T.), Neuroscience (A.R.R., V.F., C.V.L.T., T.A., P.T., M.W.H., R.I.M.), Neurology (K.W., U.N., M.W.H.), and Behavioral Medicine and Psychiatry (M.W.H.), Rockefeller Neuroscience Institute, Department of Medicine (S.H.), and West Virginia Clinical and Translational Science Institute (S.H.), West Virginia University, Morgantown; and the Department of Neurology, Vanderbilt University, Nashville (D.O.C.).

9 papers on CoChatORCID 0000-0002-9853-4902

Most cited papers

Verified
Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
Rezai, A. R., D’Haese, P.-F., Finomore, V., Carpenter, J., Ranjan, M., Wilhelmsen, K., Mehta, R. I., Wang, P., Najib, U., Vieira Ligo Teixeira, C., et al. (2024) · New England Journal of Medicine
Alzheimer's disease research and treatmentsUltrasound and Hyperthermia Applications
Cited by 312
Verified
Focused ultrasound–mediated blood-brain barrier opening in Alzheimer’s disease: long-term safety, imaging, and cognitive outcomes
Rezai, A. R., Ranjan, M., Haut, M. W., Carpenter, J., D’Haese, P.-F., Mehta, R. I., Najib, U., Wang, P., Claassen, D. O., Chazen, J. L., et al. (2023) · Journal of Neurosurgery
Ultrasound and Hyperthermia ApplicationsBarrier Structure and Function Studies
Cited by 111
Verified
β-Amyloid Plaque Reduction in the Hippocampus After Focused Ultrasound-Induced Blood–Brain Barrier Opening in Alzheimer’s Disease
D’Haese, P.-F., Ranjan, M., Song, A., Haut, M. W., Carpenter, J., Dieb, G., Najib, U., Wang, P., Mehta, R. I., Chazen, J. L., et al. (2020) · Frontiers in Human Neuroscience
Ultrasound and Hyperthermia ApplicationsAlzheimer's disease research and treatments
Cited by 94
Verified
Influences of dopaminergic system dysfunction on late-life depression
Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry
Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression
Cited by 89
Verified
Dopamine Agonists and the Suppression of Impulsive Motor Actions in Parkinson Disease
Wylie, S. A., Claassen, D. O., Huizenga, H. M., Schewel, K. D., Ridderinkhof, K. R., Bashore, T. R., & van den Wildenberg, W. P. M. (2012) · Journal of Cognitive Neuroscience
Parkinson's Disease Mechanisms and TreatmentsNeural and Behavioral Psychology Studies
Cited by 76
Verified
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine
Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments
Cited by 67
Verified
Longitudinal Progression of Cognitive Decline Correlates with Changes in the Spatial Pattern of Brain 18 F-FDG PET
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., Riddle, W. R., & Initiative, F. T. A. D. N. (2013) · Journal of Nuclear Medicine
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 54
Verified
Sleep disturbances in Parkinson's disease patients and management options
Claassen, D. (2011) · Nature and Science of Sleep
Sleep and related disordersParkinson's Disease Mechanisms and Treatments
Cited by 29
Verified
Inhibitory control, working memory and coping with stress: Associations with symptoms of anxiety and depression in adults with Huntington’s disease.
Ciriegio, A. E., Watson, K. H., Pfalzer, A. C., Hale, L., Huitz, E., Moroz, S., Roth, M. C., Snow, A. L. B., Jones, M. T., Guthrie, C. S., et al. (2022) · Neuropsychology
Genetic Neurodegenerative DiseasesNeural and Behavioral Psychology Studies
Cited by 14

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.